Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Flavonoid-Based Therapies in the Early Management of Neurodegenerative Diseases.
PLZF Regulates CCR6 and Is Critical for the Acquisition and Maintenance of the Th17 Phenotype in Human Cells.
Framework for Assessment of the Usability of Lower-Extremity Robotic Exoskeletal Orthoses.
Treatment of Chronic Experimental Autoimmune Encephalomyelitis with Epigallocatechin-3-Gallate and Glatiramer Acetate Alters Expression of Heme-Oxygenase-1.
Neutralizing antibodies and fatigue as predictors of low response to interferon-beta treatment in patients with multiple sclerosis.
Glia in mammalian development and disease.
7 Tesla MRI demonstrates vascular pathology in Balo's concentric sclerosis.
The effects of heat stress on physical functioning in persons with multiple sclerosis.
Cognitive deficit is related to immune-cell beta-NGF in multiple sclerosis patients.
Matrix metalloproteinase-2 and -9 as promising benefactors in development, plasticity and repair of the nervous system.
Use of a Time-of-Flight Camera With an Omek Beckon™ Framework to Analyze, Evaluate and Correct in Real Time the Verticality of Multiple Sclerosis Patients during Exercise.
Tracking changes over time in retinal nerve fiber layer and ganglion cell-inner plexiform layer thickness in multiple sclerosis.
Modulation of a pore in the capsid of JC polyomavirus reduces infectivity and prevents exposure of the minor capsid proteins.
[Translation and cross-cultural adaptation of the Multiple Sclerosis Walking Scale (MSWS-12) into Brazilian Portuguese].
The Treatment experience, burden, and unmet needs (TRIBUNE) study - measuring the socioeconomic consequences of Multiple Sclerosis.
Aggregation of MBP in chronic demyelination.
MicroRNAs as Active Players in the Pathogenesis of Multiple Sclerosis.
Alemtuzumab for multiple sclerosis: who and when to treat?
Effects Of A Novel Orally Administered Calpain Inhibitor Snj-1945 On Immunomodulation And Neurodegeneration In A Murine Model Of Multiple Sclerosis.
Multiple deep white matter lesions mimic multiple sclerosis as an unusual complication of left atrial myxoma.
[Non-medicinal treatments of spasticity in multiple sclerosis].
Notable Increased Cerebrospinal Fluid Levels of Soluble Interleukin-6 Receptors in Neuromyelitis Optica.
[Olfactory dysfonction in multiple sclerosis: role for subventricular zone progenitors].
Interleukin-10 paradox: A potent immunoregulatory cytokine that has been difficult to harness for immunotherapy.
Preliminary Investigation of Gait Initiation and Falls in Multiple Sclerosis.
Pages
« first
‹ previous
…
280
281
282
283
284
285
286
287
288
…
next ›
last »